BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6106162)

  • 1. Enzymatic assembly of slow reacting substance.
    Jakschik BA; Lee LH
    Nature; 1980 Sep; 287(5777):51-2. PubMed ID: 6106162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
    Murphy RC; Hammarström S; Samuelsson B
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4275-9. PubMed ID: 41240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway.
    Falkenhein SF; MacDonald H; Huber MM; Koch D; Parker CW
    J Immunol; 1980 Jul; 125(1):163-8. PubMed ID: 6103910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of biosynthesis of slow reacting substance to intracellular glutathione concentrations.
    Parker CW; Fischman CM; Wedner HJ
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6870-3. PubMed ID: 6109285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187.
    Parker CW; Falkenhein SF; Huber MM
    Prostaglandins; 1980 Nov; 20(5):863-86. PubMed ID: 6110221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells.
    Jakschik BA; Falkenhein S; Parker CW
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4577-81. PubMed ID: 22078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow-reacting substances and their formation by a lipoxygenase pathway.
    Piper PJ; Samhoun MN; Tippins JR; Morris HR; Taylor GW
    Agents Actions; 1980 Dec; 10(6):541-7. PubMed ID: 6115549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid structural requirements for leukotriene biosynthesis.
    Jakschik BA; Sams AR; Sprecher H; Needleman P
    Prostaglandins; 1980 Aug; 20(2):401-10. PubMed ID: 6106262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow-reacting substances and their structural elucidation.
    Piper PJ; Samhoun MN; Tippins JR; Morris HR; Taylor GW
    Ciba Found Symp; 1980; 78():203-15. PubMed ID: 6110523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene D: a slow reacting substance from rat basophilic leukemia cells.
    Orning L; Hammarström S; Samuelsson B
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2014-7. PubMed ID: 6103542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotrienes.
    Hammarström S
    Annu Rev Biochem; 1983; 52():355-77. PubMed ID: 6311078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of leukotriene B4, its all trans isomers and 5-hydroxyeicosatetraenoic acid by rat basophilic leukaemia cells.
    Ford-Hutchinson AW; Piper PJ; Samhoun MN
    Br J Pharmacol; 1982 May; 76(1):215-20. PubMed ID: 6282374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow reacting substance (SRS) from ionophore A23187-stimulated human leukemic basophils. I. Evidence for a precursor role of arachidonic acid and initial purification.
    Yecies LD; Wedner HJ; Parker CW
    J Immunol; 1979 Dec; 123(6):2814-6. PubMed ID: 41019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of slow reacting substance-like activity in rabbit conjunctiva and anterior uvea.
    Kulkarni PS; Srinivason BD
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1079-85. PubMed ID: 6135672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of leukotrienes E3, E4 and E5 in rat basophilic leukemia cells.
    Orning L; Bernström K; Hammarström S
    Eur J Biochem; 1981 Nov; 120(1):41-5. PubMed ID: 6273168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow reacting substances (SRSs): the structure identification of SRSs from rat basophil leukaemia (RBL-1) cells.
    Morris HR; Taylor GW; Piper PJ; Samhoun MN; Tippins JR
    Prostaglandins; 1980 Feb; 19(2):185-201. PubMed ID: 6104346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of leukotriene formation by various acetylenic acids.
    Jakschik BA; DiSantis DM; Sankarappa SK; Sprecher H
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():127-35. PubMed ID: 6124097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene generation by eosinophils.
    Jörg A; Henderson WR; Murphy RC; Klebanoff SJ
    J Exp Med; 1982 Feb; 155(2):390-402. PubMed ID: 6120203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of slow reacting substances (SRSs) of rat basophilic leukemia (RBL-1) cells: effect of cysteine on SRS profile.
    Sok DE; Pai JK; Atrache V; Sih CJ
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6481-5. PubMed ID: 6109281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow reacting substance (SRS) from ionophore A23187-stimulated peritoneal mast cells of the normal rat. II. Evidence for a precursor role of arachidonic acid and further purification.
    Yecies LD; Johnson SM; Wedner HJ; Parker CW
    J Immunol; 1979 May; 122(5):2090-5. PubMed ID: 376731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.